Although studies have shown that the sPD-L1 level can be used as a potential biomarker for lung cancer screening and staging prediction 47, high levels of sPD-L1 are associated with poorer survival in patients with NSCLC 48. This evidence concerns the gene SPDL1 and lung cancer.